News

Natco Pharma launches epilepsy drug in India

The company has launched Brivaracetam tablets under brand BRECITA

Natco Pharma has launched the epilepsy treatment drug ‘Brivaracetam’ in the country. The company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing.

THIS CAN BE YOUR ADVERTISEMENT

Brivaracetam, indicated towards the treatment of epilepsy, is developed by UCB Pharma and currently marketed in India by Dr Reddy’s under the brand name Briviact.

Natco Pharma said epilepsy patients in India are estimated to be between 5-10 million, as per GEMIND guidelines. Natco has launched BRECITA tablets in strengths of 50 mg and 100 mg priced at Rs 25 and Rs 35 per tablet, respectively. 

PTI

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close